Skip to content

Solidpharma

Active
Private limited companyfounded 2010active for 16 yearsHeistraat 16, 9052 Gent, BelgiumKBO/BCE: BE 0826.168.103
Summary

Solidpharma has been active since 2010 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €733,170 and a net result of €163,718. Equity is shrinking by about 3.7% per year across the filed financial years. Its solvency ranks better than 45% of 12,686 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).

Overview

Activity
Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
NACE 47741Wholesale of pharmaceutical and medical goods NACE 46460
1 site
Size
€2.3mtotal assets 2025
Staff
6 FTE
Equity
€733,170
Profit
€163,718
Turnover not published (abbreviated format)
Financial health
86 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.3%
Structure
Parent
Namalno · 100%
2025 accounts filed 3 days late9 deeds in the Belgian Official Gazette
Why 86raises riskSector: Retail trade (NACE 47)lowers riskFounded in 2010Figures for financial year 2025 (filed 05-01-2026)Liquidity: current ratio 1.30, cash €296,454Show the evidence

Checked score

Score 2025
86 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 56% of its sector peers (NACE 47, micro)
Financial strength · tick = 2024
Average
Solvency 57+7
equity 32.1% of total assets
Liquidity 34+12
short-term debt 62.1% · cash 13.0%
Profitability 78+21
return on assets 7.2%
Bankruptcy probability, 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%

About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,248 companies, NACE 47, micro)
Last 24 months 11-2024: 0.6% 12-2024: 0.7%▲ +0.1 percentage points vs 11-2024 01-2025: 1.2%▲ +0.5 percentage points vs 12-2024 02-2025: 0.8%▼ -0.4 percentage points vs 01-2025 03-2025: 0.8%● unchanged vs 02-2025 04-2025: 0.8%● unchanged vs 03-2025 05-2025: 0.8%● unchanged vs 04-2025 06-2025: 0.8%● unchanged vs 05-2025 07-2025: 0.8%● unchanged vs 06-2025 08-2025: 0.8%● unchanged vs 07-2025 09-2025: 0.8%● unchanged vs 08-2025 10-2025: 0.8%● unchanged vs 09-2025 11-2025: 0.8%● unchanged vs 10-2025 12-2025: 1.1%▲ +0.3 percentage points vs 11-2025 01-2026: 1.7%▲ +0.6 percentage points vs 12-2025highest value 02-2026: 0.2%▼ -1.5 percentage points vs 01-2026lowest value 03-2026: 0.2%● unchanged vs 02-2026lowest value 04-2026: 0.2%● unchanged vs 03-2026lowest value 05-2026: 0.2%● unchanged vs 04-2026lowest value 06-2026: 0.2%● unchanged vs 05-2026lowest value 07-2026: 0.2%● unchanged vs 06-2026 08-2026: 0.2%● unchanged vs 07-2026 09-2026: 0.3%▲ +0.1 percentage points vs 08-2026 10-2026: 0.3%● unchanged vs 09-2026
Credit of up to €60,000 on 30-day terms is acceptable
Liquidity tight (current ratio 1.3, compared with 1.06 in 2024, below the usual 1.5; short-term debt: 62.1% and cash: 13% of total assets), and 67.9% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 48% on solvency, 31% on liquidity, 67% on profitability and 79% on growth.

The bankruptcy probability was computed on 27-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises risk
lowers risk · Founded in 2010
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
raises risk · Sector: Retail trade (NACE 47)
KBO
lowers risk · Figures for financial year 2025 (filed 05-01-2026)
NBB · annual accounts
lowers risk · Liquidity: current ratio 1.30, cash €296,454
NBB · annual accounts
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
18192021232425
2018 to 2025 · latest year €733,170
raises risk · 2025 accounts filed 3 days late
The financial year that closed on 31-05-2025 was due by 31-12-2025 and was filed on 03-01-2026, 3 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
3 days late
2024
6 days late
2023
3 days late
2021
31 days late
2020
30 days late
2019
77 days early
2018
55 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 8 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 31-05-2026 is due by 31-12-2026. Nothing is late today. The company usually files around 3 January (3 of the last 3 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
31-05-2026 year end28-10-2026 today31-12-2026 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · abbreviated…
  2. Annual accounts filedfinancial year 2024 · abbreviated…
  3. Weakest financial yearnet €14,558 ▼93.6%

Financials · financial year 2025, abbreviated format

2025 annual accounts filed late (3 days) Filed on 3 January 2026, deadline 31 December 2025 (7 months after the close on 31 May 2025, Companies Code art. 3:10). Source: NBB, 2026-00000902.

Equity
€733,170▲ 28.7%
2024 · €569,453
Total assets
€2.3m▲ 1.9%
2024 · €2.2m
Net result
€163,718▲ 11×
2024 · €14,558
Working capital
€419,479▲ 377%
2024 · €87,857
Trend over the years

2020 to 2025, 5 financial years 2018 to 2025, 7 financial years

The operating result recovers in 2025; 2025 is nearly 3.8 times 2024.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result€0.4m 2025 Net result€0.2m 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 47, Retail trade: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).

Every figure with its change against the financial year before
favourable unfavourable
Line2018201920202021202320242025
Operating result€0.3m-€0.6m▲ 83.8%€0.9m▲ 64.3%€0.3m▼ 71.4%€0.3m-€0.09m▼ 72.5%€0.4m▲ 276%
Net result€0.2m-€0.4m▲ 89.9%€0.7mabove the sector's middle half▲ 73.6%€0.2mabove the sector's middle half▼ 73.1%€0.2mabove the sector's middle half-€0.01mwithin the sector's middle half▼ 93.6%€0.2mabove the sector's middle half▲ 11×
Equity€0.7m-€1.1m▲ 55.6%€0.9mabove the sector's middle half▼ 18.0%€0.3mwithin the sector's middle half▼ 63.2%€0.6mwithin the sector's middle half-€0.6mwithin the sector's middle half▲ 2.6%€0.7mabove the sector's middle half▲ 28.7%
Total assets€0.9m-€1.2m▲ 43.1%€2.2mabove the sector's middle half▲ 78.4%€1.6mabove the sector's middle half▼ 25.7%€2.2mabove the sector's middle half-€2.2mabove the sector's middle half▲ 1.5%€2.3mabove the sector's middle half▲ 1.9%
Debt€0.2m-€0.1m▼ 10.1%€1.3m▲ 790%€1.3m▼ 0.2%€1.6m-€1.7m▲ 1.2%€1.5m▼ 7.2%
Working capital€0.6m-€1.0m▲ 63.3%€0.8mabove the sector's middle half▼ 18.1%€0.2mwithin the sector's middle half▼ 74.7%€0.008mbelow the sector's middle half-€0.09mwithin the sector's middle half▲ 936%€0.4mabove the sector's middle half▲ 377%
Solvency81.0%-88.1%▲ 7.1pp40.5%within the sector's middle half▼ 47.6pp20.1%within the sector's middle half▼ 20.4pp25.2%within the sector's middle half-25.4%within the sector's middle half▲ 0.3pp32.1%within the sector's middle half▲ 6.7pp
Current ratio5.57-8.46▲ 2.891.65within the sector's middle half▼ 6.811.17within the sector's middle half▼ 0.491.01below the sector's middle half-1.06within the sector's middle half▲ 0.051.30within the sector's middle half▲ 0.24
Return on assets (ROA)23.7%-31.5%▲ 7.8pp30.6%above the sector's middle half▼ 0.8pp11.1%within the sector's middle half▼ 19.5pp10.4%within the sector's middle half-0.7%within the sector's middle half▼ 9.7pp7.2%within the sector's middle half▲ 6.5pp
Staff (FTE)2.7-2.5▼ 7.4%1.3below the sector's middle half▼ 48.0%2.7within the sector's middle half▲ 108%5.6within the sector's middle half-6.9within the sector's middle half▲ 23.2%6within the sector's middle half▼ 13.0%
above within below the middle half of NACE 47, Retail trade: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the abbreviated format does not require them.
Why a figure moved sharply
  • 2024 Net result -94% on 2023. The previous financial year ran 17 months, this one 12.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €2.3m
Fixed assets €445,350 ▼ 26.3%
Current assets €1.8m ▲ 12.4%
Equity and liabilities €2.3m
Equity €733,170 ▲ 28.7%
Debt €1.5m ▼ 7.2%
Debt's share of the balance-sheet total falls from 74.6% to 67.9%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€524,855▲
2024 · €256,022
Cash flow
€334,632▲
2024 · €176,337
Quick ratio
0.63▲
2024 · 0.48
Debt to equity
2.11▼
2024 · 2.93
ROE
22.3%▲
2024 · 2.6%
Interest coverage
6.72▲
2024 · 4.53
Debt ≤ 1 year
€1.4m▼
2024 · €1.5m
Debt > 1 year
€77,071▼
2024 · €100,000
Income taxes
€114,789▲
2024 · €24,942
Staff costs
€610,717▲
2024 · €565,661
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 34,693 companies that looked in July 2024 the way this one looks now, 0.7% went bankrupt within 24 months and 95.3% are still going.

  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
0.7% went bankrupt
3.9% stopped otherwise
95.3% still going

For this company itself Checked computes a bankruptcy probability of 0.3% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,445 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 34,693 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 57 lines
Balance sheet Code20242025
Assets
Total assets20/58€2.2m€2.3m▲
Fixed assets21/28€0.6m€0.4m▼
Intangible fixed assets21€0.6m€0.4m▼
Tangible fixed assets22/27€0.04m€0.03m▼
Land and buildings22€188€0▼
Plant, machinery and equipment23€0.03m€0.02m▼
Furniture and vehicles24€0.007m€0.01m▲
Other tangible fixed assets26€0.01m€0.005m▼
Financial fixed assets28€0.004m€0.004m=
Current assets29/58€1.6m€1.8m▲
Stocks and contracts in progress3€0.9m€0.9m▲
Stocks30/36€0.9m€0.9m▲
Amounts receivable within one year40/41€0.6m€0.6m▲
Trade receivables40€0.5m€0.6m▲
Other amounts receivable41€0.1m€0.01m▼
Cash at bank and in hand54/58€0.2m€0.3m▲
Deferred charges and accrued income490/1€0.03m€0.03m▼
Equity and liabilities
Total equity and liabilities10/49€2.2m€2.3m▲
Equity10/15€0.6m€0.7m▲
Contributions10/11€0.02m€0.02m=
Reserves13€0.6m€0.7m▲
Non-distributable reserves130/1€0.006m€0.006m=
Reserves not available under the articles1311€0.006m€0.006m=
Tax-exempt reserves132€0.001m€0.001m=
Distributable reserves133€0.5m€0.7m▲
Amounts payable17/49€1.7m€1.5m▼
Amounts payable after more than one year17€0.1m€0.08m▼
Financial debts170/4€0.1m€0.08m▼
Amounts payable within one year42/48€1.5m€1.4m▼
Current portion of amounts payable after more than one year42-€0.02m
Financial debts43€0.8m€0.7m▼
Credit institutions430/8€0.8m€0.7m▼
Trade debts44€0.6m€0.6m▼
Suppliers440/4€0.6m€0.6m▼
Taxes, remuneration and social security45€0.2m€0.2m▼
Taxes450/3€0.1m€0.1m▼
Remuneration and social security454/9€0.05m€0.06m▲
Other amounts payable47/48€0-
Accrued charges and deferred income492/3€0.02m€0.05m▲
Income statement Code20242025
Non-recurring operating income76A€0-
Remuneration, social security and pensions62€0.6m€0.6m▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€0.2m€0.2m▲
Other operating charges640/8€0.003m€0.004m▲
Gross operating margin9900€0.8m€1.1m▲
Operating profit (loss)9901€0.09m€0.4m▲
Financial income75/76B€0.002m€0.003m▲
Recurring financial income75€0.002m€0.003m▲
Financial charges65/66B€0.06m€0.08m▲
Recurring financial charges65€0.06m€0.08m▲
Profit (loss) for the period before taxes9903€0.04m€0.3m▲
Income taxes67/77€0.02m€0.1m▲
Profit (loss) for the period9904€0.01m€0.2m▲
Profit (loss) for the period to be appropriated9905€0.01m€0.2m▲
Appropriation of the result
Profit (loss) to be appropriated9906€0.01m€0.2m▲
Transfer to equity691/2€0.01m€0.2m▲
To other reserves6921€0.01m€0.2m▲
Social balance sheet
Average headcount (FTE)90876.96.0▼

The notes to these accounts (16 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2018201920202021202320242025Change
Non-recurring operating income76A---€0.005m€337€0--
Remuneration, social security and pensions62---€0.2m€0.6m€0.6m€0.6m▲ 8.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€0.04m€0.04m€0.02m€0.02m€0.08m€0.2m€0.2m▲ 5.6%
Other operating charges640/8---€0.006m€0.006m€0.003m€0.004m▲ 61.8%
Non-recurring operating charges66A---€0.002m€0---
Gross operating margin9900€0.5m€0.7m€1.0m€0.5m€1.1m€0.8m€1.1m▲ 38.3%
Operating profit (loss)9901€0.3m€0.6m€0.9m€0.3m€0.3m€0.09m€0.4m▲ 276%
Financial income75/76B---€0.002m€0.005m€0.002m€0.003m▲ 52.1%
Recurring financial income75€8€2€23€0.002m€0.005m€0.002m€0.003m▲ 52.1%
Financial charges65/66B---€0.004m€0.05m€0.06m€0.08m▲ 38.2%
Recurring financial charges65€0.001m€0.001m€0.001m€0.004m€0.05m€0.06m€0.08m▲ 38.2%
Profit (loss) for the period before taxes9903€0.3m€0.6m€0.9m€0.3m€0.3m€0.04m€0.3m▲ 605%
Income taxes67/77€0.1m€0.2m€0.2m€0.08m€0.07m€0.02m€0.1m▲ 360%
Profit (loss) for the period9904€0.2m€0.4m€0.7m€0.2m€0.2m€0.01m€0.2m▲ 11×
Profit (loss) for the period to be appropriated9905€0.2m€0.4m€0.7m€0.2m€0.2m€0.01m€0.2m▲ 11×
Line2018201920202021202320242025Change
Assets
Total assets20/58€0.9m€1.2m€2.2m€1.6m€2.2m€2.2m€2.3m▲ 1.9%
Fixed assets21/28€0.08m€0.05m€0.04m€0.1m€0.5m€0.6m€0.4m▼ 26.3%
Intangible fixed assets21€0.001m€287-€0.02m€0.5m€0.6m€0.4m▼ 26.6%
Tangible fixed assets22/27€0.08m€0.05m€0.04m€0.08m€0.06m€0.04m€0.03m▼ 25.4%
Land and buildings22---€0.001m€471€188€0▼ 100%
Plant, machinery and equipment23---€0.04m€0.03m€0.03m€0.02m▼ 39.3%
Furniture and vehicles24---€0.02m€0.01m€0.007m€0.01m▲ 83.5%
Other tangible fixed assets26---€0.03m€0.02m€0.01m€0.005m▼ 56.3%
Financial fixed assets28€275€275€275€0.004m€0.004m€0.004m€0.004m=
Current assets29/58€0.8m€1.2m€2.1m€1.5m€1.7m€1.6m€1.8m▲ 12.4%
Stocks and contracts in progress3€0.06m€0.1m€0.2m€0.5m€0.9m€0.9m€0.9m▲ 5.9%
Stocks30/36---€0.5m€0.9m€0.9m€0.9m▲ 5.9%
Amounts receivable within one year40/41€0.1m€0.2m€0.6m€0.5m€0.4m€0.6m€0.6m▲ 1.7%
Trade receivables40---€0.4m€0.3m€0.5m€0.6m▲ 20.0%
Other amounts receivable41---€0.06m€0.07m€0.1m€0.01m▼ 87.9%
Cash at bank and in hand54/58€0.6m€0.8m€1.3m€0.5m€0.3m€0.2m€0.3m▲ 91.7%
Deferred charges and accrued income490/1---€0.04m€0.02m€0.03m€0.03m▼ 3.2%
Equity and liabilities
Total equity and liabilities10/49€0.9m€1.2m€2.2m€1.6m€2.2m€2.2m€2.3m▲ 1.9%
Equity10/15€0.7m€1.1m€0.9m€0.3m€0.6m€0.6m€0.7m▲ 28.7%
Contributions10/11€0.02m€0.02m-€0.02m€0.02m€0.02m€0.02m=
Reserves13€0.6m€1.0m€0.9m€0.3m€0.5m€0.6m€0.7m▲ 29.7%
Non-distributable reserves130/1---€0.006m€0.006m€0.006m€0.006m=
Reserves not available under the articles1311---€0.006m€0.006m€0.006m€0.006m=
Tax-exempt reserves132---€0.001m€0.001m€0.001m€0.001m=
Distributable reserves133---€0.3m€0.5m€0.5m€0.7m▲ 30.1%
Profit (loss) carried forward14€0.04m€0.04m-€0€0---
Amounts payable17/49€0.2m€0.1m€1.3m€1.3m€1.6m€1.7m€1.5m▼ 7.2%
Amounts payable after more than one year17€0.02m€0.008m---€0.1m€0.08m▼ 22.9%
Financial debts170/4-----€0.1m€0.08m▼ 22.9%
Amounts payable within one year42/48€0.1m€0.1m€1.3m€1.3m€1.6m€1.5m€1.4m▼ 8.3%
Current portion of amounts payable after more than one year42---€0--€0.02m-
Financial debts43----€0.9m€0.8m€0.7m▼ 15.4%
Credit institutions430/8----€0.9m€0.8m€0.7m▼ 15.4%
Trade debts44€0.1m€0.08m€0.3m€0.3m€0.5m€0.6m€0.6m▼ 2.3%
Suppliers440/4---€0.3m€0.5m€0.6m€0.6m▼ 2.3%
Taxes, remuneration and social security45---€0.2m€0.2m€0.2m€0.2m▼ 8.2%
Taxes450/3---€0.2m€0.2m€0.1m€0.1m▼ 17.6%
Remuneration and social security454/9---€0.02m€0.03m€0.05m€0.06m▲ 15.4%
Other amounts payable47/48---€0.8m€0.07m€0--
Accrued charges and deferred income492/3-----€0.02m€0.05m▲ 139%
Line2018201920202021202320242025Change
Profit (loss) for the period9904€203,285€386,092€670,192€180,590€228,679€14,558€163,718▲ 11×
+ Depreciation and write-downs630€39,747€35,169€15,657€22,055€79,579€161,779€170,914▲ 5.6%
Operating cash flow (approximation)€243,031€421,260€685,849€202,645€308,258€176,337€334,632▲ 89.8%
Investment in fixed assets (approximation)--€3,723-€907-€95,258--€219,818-€11,814▲ 94.6%
Change in cash-€253,508€468,055-€827,472--€172,564€141,833-

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Latest 10 of 14 filings with the National Bank
Financial year Type Filed Reference
31-05-2025 abbreviated format 03-01-2026 2026-00000902
31-05-2024 abbreviated format 06-01-2025 2025-00000971
31-05-2023 abbreviated format 03-01-2024 2024-00541540
31-12-2021 abbreviated format 31-08-2022 2022-20412386
31-12-2020 abbreviated format 30-08-2021 2021-59100074
31-12-2019 abbreviated format 15-05-2020 2020-12500549
31-12-2018 abbreviated format 06-06-2019 2019-17200205
31-12-2017 abbreviated format 08-06-2018 2018-17100276
31-12-2016 abbreviated format 23-08-2017 2017-47300393
31-12-2015 abbreviated format 20-05-2016 2016-12800128

Show all 14 filings

Similar companies · same sector, comparable size

Of the 1,049 active companies whose main activity is retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses (NACE 47741), figures are known for 652. 408 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector

Subsidies and aid

Flemish government

2022 to 2025 · 7 entries · €61,939 awarded · €11,939 paid
Year Entries AwardedPaid
2025 2 €0€0
2024 2 €50,209€209
2023 2 €11,205€11,205
2022 1 €525€525
Schemes
3 entries · €50,000 · Fonds voor Innoveren en Ondernemen
1 entry · €9,000 · €9,000 paid · Vlaams Agentschap voor Internationaal Ondernemen
3 entries · €2,939 · €2,939 paid · Fonds voor Innoveren en Ondernemen

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
No directors read yet: 0 of 9 Gazette acts processed. See the directors and other office holders in the KBO →

Owners and capital

Owners

1 owner

Chain of control

  1. Namalno 100%
  2. Solidpharma

Highest known parent: Namalno. The sources do not say who stands above it.

Owners 1

Sources: the companies' annual accounts, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.

Group and network

Connections & network

Depth

The network starts from this company’s shareholders. What else they own or run appears here as nodes.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.

History

Solidpharma was incorporated on 19 May 2010.1 Total assets rose from €856,989 in 2018 to €2.3m in 2025 and headcount from 2.7 to 6 full-time equivalents.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2018 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-12-2026
2026
03-01
NBB filing Annual accounts filed
financial year 2025 · abbreviated format · 3 days late
2025
06-01
NBB filing Annual accounts filed
financial year 2024 · abbreviated format · 6 days late
2024
31-05
Financial Weakest financial yearnet €14,558 ▼93.6%
Net result drops to €14,558, the lowest in the series; recovery starts the following year.
03-01
NBB filing Annual accounts filed
financial year 2023 · abbreviated format · 3 days late
2023
31-05
Financial Equity above €500,000equity €554,895 ▲70.1%
A profit in every financial year since 2018 builds equity to €554,895.
2022
31-08
NBB filing Annual accounts filed
financial year 2021 · abbreviated format · 31 days late
2021
30-08
NBB filing Annual accounts filed
financial year 2020 · abbreviated format · 30 days late
2020
31-12
Financial Highest result from 2018 to 2025net €670,192 ▲73.6%
Operating result €906,074, net result €670,192, both a record.
15-05
NBB filing Annual accounts filed
financial year 2019 · abbreviated format
2019
31-12
Financial Equity above €1mequity €1.1m ▲55.6%
A profit in every financial year since 2018 builds equity to €1.1m.
06-06
NBB filing Annual accounts filed
financial year 2018 · abbreviated format
2018
08-06
NBB filing Annual accounts filed
financial year 2017 · abbreviated format
2017
23-08
NBB filing Annual accounts filed
financial year 2016 · abbreviated format · 23 days late
2016
20-05
NBB filing Annual accounts filed
financial year 2015 · abbreviated format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 14 annual accounts filed, the latest 10 are here; all 14 are under Financials.
0 of 9 deeds read
About the unread acts

We know of 9 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Register details

Identification
Legal formPrivate limited company
Founded19-05-2010
Financial year end31-05
Activities, NACEBEL 2025
46460Wholesale of pharmaceutical and medical goods
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
47730Retail sale of pharmaceutical products
E-invoicing
Reachable via Peppol
Peppol ID 0208:0826168103
Registered 05-01-2026

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 27 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Recognitions · licences · registrations

Food safety, FASFC

1 site
Gentunit no. 2.189.706.011
1 permission
Groothandelaar LM>3 maand · since 14-07-2020

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Gent · 1 establishment unit since 2010
registered office establishment The establishment unit on the map
Ground area
262 m²
Building footprint
262 m²
Building volume
2,911 m³
Parcel 44082A0335/00B000, Flanders · tallest building 15.1 m. Linked by address, not a title deed.
6 companies at this address See who is registered here
1 establishment unit
SOLIDPHARMA
Heistraat 16, 9052 GentAgents in the wholesale of food, beverages and tobacco
since 2010unit no. 2.189.706.011
1 parcel
Flanders 1 (100%)
Cadastral parcel Region Area Buildings Height / floors
44082A0335/00B000
ProtectedCultural-historical landscape · MonumentKastelensiteSource ↗
Flanders 262 m² 1 · 262 m² 15.1 m · 4
How the parcels are linked
Good to know
The parcel matches the address exactly.
1 of these parcels carries protected heritage: expect extra rules on renovation or sale.